Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
NRG Oncology
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Mayo Clinic
National Cancer Institute (NCI)
NRG Oncology
NYU Langone Health
Rigshospitalet, Denmark